These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36539991)

  • 1. Medicinal cannabis improves sleep in adults with insomnia: a randomised double-blind placebo-controlled crossover study.
    Ried K; Tamanna T; Matthews S; Sali A
    J Sleep Res; 2023 Jun; 32(3):e13793. PubMed ID: 36539991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial.
    Suraev A; McCartney D; Marshall NS; Irwin C; Vandrey R; Grunstein RR; D'Rozario AL; Gordon C; Bartlett D; Hoyos CM; McGregor IS
    Psychopharmacology (Berl); 2024 Sep; 241(9):1815-1825. PubMed ID: 38758300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.
    Gurgenci T; Hardy J; Huggett G; Foster K; Pelecanos A; Greer R; Philip J; Haywood A; Mendis R; Yates P; Good P
    Trials; 2024 May; 25(1):293. PubMed ID: 38693590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo.
    Walsh JH; Maddison KJ; Rankin T; Murray K; McArdle N; Ree MJ; Hillman DR; Eastwood PR
    Sleep; 2021 Nov; 44(11):. PubMed ID: 34115851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol (CBD) and Δ
    Suraev A; Grunstein RR; Marshall NS; D'Rozario AL; Gordon CJ; Bartlett DJ; Wong K; Yee BJ; Vandrey R; Irwin C; Arnold JC; McGregor IS; Hoyos CM
    BMJ Open; 2020 May; 10(5):e034421. PubMed ID: 32430450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder.
    Kunz D; Dauvilliers Y; Benes H; García-Borreguero D; Plazzi G; Seboek Kinter D; Coloma P; Rausch M; Sassi-Sayadi M; Thein S
    CNS Drugs; 2023 Jan; 37(1):93-106. PubMed ID: 36484969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial.
    Fietze I; Bassetti CLA; Mayleben DW; Pain S; Seboek Kinter D; McCall WV
    Drugs Aging; 2022 Oct; 39(10):795-810. PubMed ID: 36098936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study.
    De Cock VC; Dodet P; Leu-Semenescu S; Aerts C; Castelnovo G; Abril B; Drapier S; Olivet H; Corbillé AG; Leclair-Visonneau L; Sallansonnet-Froment M; Lebouteux M; Anheim M; Ruppert E; Vitello N; Eusebio A; Lambert I; Marques A; Fantini ML; Devos D; Monaca C; Benard-Serre N; Lacombe S; Vidailhet M; Arnulf I; Doulazmi M; Roze E
    Lancet Neurol; 2022 May; 21(5):428-437. PubMed ID: 35429481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol for moderate-severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing.
    Narayan AJ; Downey LA; Rose S; Di Natale L; Hayley AC
    J Clin Sleep Med; 2024 May; 20(5):753-763. PubMed ID: 38174873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin treatment effects on adolescent students' sleep timing and sleepiness in a placebo-controlled crossover study.
    Eckerberg B; Lowden A; Nagai R; Akerstedt T
    Chronobiol Int; 2012 Nov; 29(9):1239-48. PubMed ID: 23005039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N
    BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin in elderly patients with insomnia. A systematic review.
    Olde Rikkert MG; Rigaud AS
    Z Gerontol Geriatr; 2001 Dec; 34(6):491-7. PubMed ID: 11828891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
    Wade AG; Crawford G; Ford I; McConnachie A; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2011 Jan; 27(1):87-98. PubMed ID: 21091391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
    Ancoli-Israel S; Krystal AD; McCall WV; Schaefer K; Wilson A; Claus R; Rubens R; Roth T
    Sleep; 2010 Feb; 33(2):225-34. PubMed ID: 20175406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials.
    Mignot E; Mayleben D; Fietze I; Leger D; Zammit G; Bassetti CLA; Pain S; Kinter DS; Roth T;
    Lancet Neurol; 2022 Feb; 21(2):125-139. PubMed ID: 35065036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.
    Zemlan FP; Mulchahey JJ; Scharf MB; Mayleben DW; Rosenberg R; Lankford A
    J Clin Psychiatry; 2005 Mar; 66(3):384-90. PubMed ID: 15766306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of suanzaoren decoction for chronic insomnia disorder in adults: study protocol for randomised, double-blind, double-dummy, placebo-controlled trial.
    Zhou QH; Wang HL; Zhou XL; Xu MB; Zhang HF; Huang LB; Zheng GQ; Lin Y
    BMJ Open; 2017 Apr; 7(4):e014280. PubMed ID: 28377394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis for the treatment of Crohn's disease.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
    Rajaratnam SM; Polymeropoulos MH; Fisher DM; Roth T; Scott C; Birznieks G; Klerman EB
    Lancet; 2009 Feb; 373(9662):482-91. PubMed ID: 19054552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.